These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3305972)

  • 21. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioassays for carcinogenicity in animals. Assays for initiating and promoting activities.
    Bannasch P; Griesemer RA; Anders F; Becker R; Cabral JR; Della Porta G; Feron VJ; Henschler D; Ito N; Kroes R
    IARC Sci Publ; 1986; (83):103-26. PubMed ID: 3305339
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutagenicity and carcinogenicity correlations between bacteria and rodents.
    Brusick D
    Ann N Y Acad Sci; 1983; 407():164-76. PubMed ID: 6349473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for the testing of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1982; 25():1-30. PubMed ID: 6765817
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative results of 327 chemical carcinogenicity studies.
    Haseman JK; Huff JE; Zeiger E; McConnell EE
    Environ Health Perspect; 1987 Oct; 74():229-35. PubMed ID: 3691430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descriptive summaries of the data on the basis of which the chemicals, industrial processes and industries were evaluated for carcinogenicity to humans.
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1982 Oct; (4):25-276. PubMed ID: 6963264
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modification of the processes of chemical mutagenesis and carcinogenesis by synthetic phenol antioxidants such as butylated hydroxyanisole].
    Demkowicz-Dobrzański K; Hennig EE
    Postepy Biochem; 1992; 38(1):37-42. PubMed ID: 1508778
    [No Abstract]   [Full Text] [Related]  

  • 28. Carcinogenicity testing of antitumor agents.
    Hottendorf GH
    Toxicol Pathol; 1985; 13(3):192-9. PubMed ID: 4070930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The weight of the evidence among group C carcinogens.
    Engler R; Rinde E; Frick C; Quest J
    Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
    Parry JM
    IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
    [No Abstract]   [Full Text] [Related]  

  • 31. Genotoxicty and mutagenicity.
    Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
    [No Abstract]   [Full Text] [Related]  

  • 32. Rational decision points in carcinogenicity bioassays based on mechanisms of mutagenesis and carcinogenesis.
    Weisburger JH; Williams GM
    Prog Clin Biol Res; 1986; 209B():91-8. PubMed ID: 3749111
    [No Abstract]   [Full Text] [Related]  

  • 33. Issues of biochemical applications to risk assessment: how should the MTD be selected for chronic bioassays?
    Kociba RJ
    Environ Health Perspect; 1987 Dec; 76():169-74. PubMed ID: 3447894
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative carcinogenicity of ring-halogenated 3-methyl-1-phenyltriazenes and their 3,3-dimethyl analogs at equimolar dose levels in male Sprague-Dawley rats.
    Berger MR; Kolar GF
    J Cancer Res Clin Oncol; 1986; 111(2):129-32. PubMed ID: 3700457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical parameters for quantification of mutational responses in bacteria.
    Roldán-Arjona T; Pueyo C; Haynes RH
    Mutat Res; 1995 Feb; 346(2):77-84. PubMed ID: 7885403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogenicity testing and safety assessment.
    Squire RA
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 2):S326-34. PubMed ID: 6745551
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of the carcinogenicity prediction and battery selection (CPBS) method to the Gene-Tox data base.
    Pet-Edwards J; Chankong V; Rosenkranz HS; Haimes YY
    Mutat Res; 1985 May; 153(3):187-200. PubMed ID: 3990701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the carcinogenic risk of environmental chemicals].
    Ito N; Imaida K; Ogiso T; Tamano S; Kurata Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3345-53. PubMed ID: 3789750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro-In Vivo Carcinogenicity.
    Steinberg P
    Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.